Cirrhosis decreases vasoconstrictor response to electrical field stimulation in rat mesenteric artery: Role of calcitonin gene-related peptide

Experimental Physiology

Volumn 96, Issue 3, 2011, Pages 275-286

  Blanco Rivero, Javier ^a   Márquez Rodas, Iván ^b   Sastre, Esther ^a   Cogolludo, Ángel ^c   Pérez Vizcaíno, Francisco ^c   Del Campo, Lara ^a   Nava, Ma Paz ^c   Balfagón, Gloria ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; CALCITONIN RECEPTOR LIKE RECEPTOR; CYCLIC GMP; GLIBENCLAMIDE; GUANOSINE PHOSPHATE; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; PINACIDIL; RECEPTOR ACTIVITY MODIFYING PROTEIN; SULFONYLUREA RECEPTOR; SYNAPSIN I; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTRIC FIELD; ELECTROSTIMULATION; LIVER CIRRHOSIS; MALE; MESENTERIC ARTERY; MUSCLE CELL; NONHUMAN; PATCH CLAMP; RAT; SPLANCHNIC NERVE; VASOCONSTRICTION; VASODILATATION;

EID: 79951518130     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2010.055822     Document Type: Article

References (52)

1. Balfagón G, Márquez-Rodas I, Alvarez Y, Alonso MJ, Cachofeiro V, Salaices M & Lahera V (2004). Aldosterone modulates neural vasomotor response in hypertension: role of calcitonin gene-related peptide. Regul Pept 120, 253-260.
2. Battaglia S, Angus P & Chin-Dusting JP (2006). Role of the endothelium on vasoactive agents in patients with liver cirrhosis. J Gastroenterol Hepatol 21, 1189-1193.
3. Bendtsen F, Schifter S & Henriksen JH (1991). Increased circulating calcitonin gene-related peptide (CGRP) in cirrhosis. J Hepatol 12, 118-123.
4. ATP channels. Eur J Pharmacol 587, 204-208.
5. Brain SD & Grant AD (2004). Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84, 903-934.
6. ATP channels in vascular smooth muscle. Clin Exp Pharmacol Physiol 29, 312-316.
7. Buñag RD (1973). Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol 34, 279-282.
8. 2. Role in vasodilation. Cardiovasc Res 73, 424-431.
9. Coll M, Genescà J, Raurell I, Rodríguez-Vilarrupla A, Mejías M, Otero T, Oria M, Esteban R, Guardia J, Bosch J & Martell M (2008). Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension. J Hepatol 49, 43-51.
10. Coll M, Martell M, Raurell I, Ezkurdia N, Cuenca S, Hernández-Losa J, Esteban R, Guardia J, Bosch J & Genescà J (2010). Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension. Liver Int 30, 593-602.
11. Corcuera MT, Nava MP, Angulo A, Aller MA, Gomez F, Casado I, Alonso MJ & Arias J (2005). Remodelación esplácnica secundaria a hipertensión portal prehepática experimental. An Med Int 22, 317-322.
12. Cueille C, Pidoux E, de Vernejoul MC, Ventura-Clapier R & Garel JM (2002). Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure. Biochem Biophys Res Commun 294, 340-346.
13. de Hoon JN, Pickkers P, Smits P, Struijker-Boudier HA & Van Bortel LM (2003). Calcitonin gene-related peptide: exploring its vasodilating mechanism of action in humans. Clin Pharmacol Ther 73, 312-321.
14. del Campo L, Ferrer M & Balfagón G (2009). Hypertension alters the function of nitrergic and sensory innervation in mesenteric arteries from female rats. J Hypertens 27, 791-799.
15. De Mey JG, Megens R & Fazzi GE (2008). Functional antagonism between endogenous neuropeptide Y and calcitonin gene-related peptide in mesenteric resistance arteries. J Pharmacol Exp Ther 324, 930-937.
16. Diéguez B, Aller MA, Nava MP, Palma MD, Arias JL, López L & Arias J (2002). Chronic portal hypertension in the rat by triple-portal stenosing ligation. J Invest Surg 15, 329-336.
17. Ebrahimkhani MR, Moezi L, Kiani S, Merat S & Dehpour AR (2008). Opioid receptor blockade improves mesenteric responsiveness in biliary cirrhosis. Dig Dis Sci 53, 3007-3011.
18. Fang HL, Lai JJ, Lin WL & Lin WC (2007). A fermented substance from Aspergillus phoenicis reduces liver fibrosis induced by carbon tetrachloride in rats. Biosci Biotechnol Biochem 71, 1154-1161.
19. Ferrer M, Alonso MJ, Salaices M, Marín J & Balfagón G (2000). Increase in neurogenic nitric oxide metabolism by endothelin-1 in mesenteric arteries from hypertensive rats. J Cardiovasc Pharmacol 36, 541-547.
20. Ferrer M, Alonso MJ, Salaices M, Marín J & Balfagón G (2001). Angiotensin II increases neurogenic nitric oxide metabolism in mesenteric arteries from hypertensive rats. Life Sci 68, 1169-1179.
21. Ferrer M, Salaices M & Balfagón G (2004). Endogenous prostacyclin increases neuronal nitric oxide release in mesenteric artery from spontaneously hypertensive rats. Eur J Pharmacol 506, 151-156.
22. Gatta A, Bolognesi M & Merkel C (2008). Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis. Mol Aspects Med 29, 119-129.
23. Hennenberg M, Biecker E, Trebicka J, Jochem K, Zhou Q, Schmidt M, Jakobs KH, Sauerbruch T & Heller J (2006). Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats. Gastroenterology 130, 838-854.
24. Henriksen JH, Moller S, Schifter S & Bendtsen F (1999). Increased arterial compliance in decompensated cirrhosis. J Hepatol 31, 712-718.
25. Iwakiri Y (2007). The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension. J Clin Gastroenterol 41, 288-294.
26. Kawasaki H, Takasaki K, Saito A & Goto K (1988). Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature 335, 164-167.
27. Kirstetter P, Lagneau F, Le Corre F, Cailmail S, Moreau R, Lebrec D & Marty J (1998). Vascular properties of isoflurane: comparison between normal and cirrhotic rats. Br J Anaesth 81, 968-969.
28. Li YJ & Duckles SP (1992). Effect of endothelium on the actions of sympathetic and sensory nerves in the perfused rat mesentery. Eur J Pharmacol 210, 23-30.
29. Marín J & Balfagón G (1998). Effect of clenbuterol on non-endothelial nitric oxide release in rat mesenteric arteries and the involvement of β-adrenoceptors. Br J Pharmacol 124, 473-478.
30. Marín J, Ferrer M & Balfagon G (2000). Role of protein kinase C in electrical-stimulation-induced neuronal nitric oxide release in mesenteric arteries from hypertensive rats. Clin Sci (Lond) 99, 277-283.
31. Márquez-Rodas I, Longo F, Aras-López R, Blanco-Rivero J, Diéguez E, Tejerina T, Ferrer M & Balfagón G (2006a). Aldosterone increases RAMP1 expression in mesenteric arteries from spontaneously hypertensive rats. Regul Pept 134, 61-66.
32. Márquez-Rodas I, Longo F, Rothlin RP & Balfagón G (2006b). Pathophysiology and therapeutic possibilities of calcitonin gene-related peptide in hypertension. J Physiol Biochem 62, 45-56.
33. Márquez-Rodas I, Xavier FE, Arroyo-Villa I, Longo F, Aras-Lopez R, Blanco-Rivero J, Ferrer M & Balfagón G (2008). Increased expression in calcitonin-like receptor induced by aldosterone in cerebral arteries from spontaneously hypertensive rats does not correlate with functional role of CGRP receptor. Regul Pept 146, 125-130.
34. Møller S, Bendtsen F, Schifter S & Henriksen JH (1996) Relation of calcitonin gene-related peptide to systemic vasodilatation and central hypovolaemia in cirrhosis. Scand J Gastroenterol 31, 928-933.
35. Morales-Ruiz M, Jiménez W, Pérez-Sala D, Ros J, Leivas A, Lamas S, Rivera F & Arroyo V (1996). Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology 24, 1481-1486.
36. + channels by glibenclamide reduces portal pressure and hyperkinetic circulation in portal hypertensive rats. J Hepatol 16, 215-218.
37. Moreau R, Komeichi H, Kirstetter P, Ohsuga M, Cailmail S & Lebrec D (1994). Altered control of vascular tone by adenosine triphosphate-sensitive potassium channels in rats with cirrhosis. Gastroenterology 106, 1016-1023.
38. Nelson MT & Quayle JM (1995). Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol Cell Physiol 268, C799-C822.
39. Nielsen KC & Owman C (1971). Contractile response and amine receptor mechanisms in isolated middle cerebral artery of the cat. Brain Res 27, 33-42.
40. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA & Foord SM (2002). International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54, 233-246.
41. Saito A, Masaki T, Uchiyama Y, Lee TJ & Goto K. (1989). Calcitonin gene-related peptide and vasodilator nerves in large cerebral arteries of cats. J Pharmacol Exp Ther 248, 455-462.
42. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH & Rodés J (1988). Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8, 1151-1157.
43. Sexton PM, Albiston A, Morfis M & Tilakaratne N (2001). Receptor activity modifying proteins. Cell Signal 13, 73-83.
44. Stewart SF & Day CP (2003). The management of alcoholic liver disease. J Hepatol 38, 2-13.
45. Van Obbergh L, Leonard V, Chen H, Xu D & Blaise G (1995). The endothelial and non-endothelial mechanism responsible for attenuated vasoconstriction in cirrhotic rats. Exp Physiol 80, 609-617.
46. Vaughan RB, Angus JA & Angus PW (2005). Vasoconstrictor responses are normal but prostanoid-mediated vasodilatation is enhanced in human cirrhotic mesenteric arteries. J Gastroenterol Hepatol 20, 1158-1164.
47. Vedernikov YP, Fulep EE, Saade GR & Garfield RE (2002). Calcitonin gene-related peptide dilates the pregnant rat uterine vascular bed via guanylate cyclase, ATP- and Ca-sensitive potassium channels and gap junctions. Curr Med Res Opin 18, 465-470.
48. Wiest R (2007). Splanchnic and systemic vasodilation: the experimental models. J Clin Gastroenterol 41, 272-287.
49. Wimalawansa SJ (1996). Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr Rev 17, 533-585.
50. Xu L, Carter EP, Ohara M, Martin PY, Rogachev B, Morris K, Cadnapaphornchai M, Knotek M & Schrier RW (2000). Neuronal nitric oxide synthase and systemic vasodilation in rats with cirrhosis. Am J Physiol Renal Physiol 279, F1110-F1115.
51. 2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis. Liver Int 27, 1045-1055.
52. Yu XJ, Li YJ & Deng HW (1993). The regulatory effect of bradykinin on the actions of sensory nerves in the perfused rat mesentery is mediated by nitric oxide. Eur J Pharmacol 241, 35-40.